• Mosquito Xenobiotic Transport After Alizarin Exposure

  2026-09-24

  Kennel and Rouhier tested how three injected xenobiotics affect excretion and putative organic cation transporter expression in female Aedes aegypti. Their results point to a stronger effect of chemical structure on excreted material and mortality than on the measured transporter transcripts, while highlighting how much remains unknown about mosquito xenobiotic transport.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-24

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic signal that accumulates in tumor-associated macrophage lysosomes and promotes an AMPKα–STAT6–ARG1 program. The study connects cholesterol sensing to macrophage-mediated immune suppression and reports that targeting CH25H can improve antitumor responses, including with anti-PD-1 therapy.

• FAISL Stabilizes FAK to Drive TNBC Metastasis

  2026-09-23

  The study identifies FAISL, a long noncoding RNA, as a protein-level regulator of focal adhesion kinase (FAK): by binding FAK and limiting calpain 2 access, FAISL protects FAK from proteolysis and supports triple-negative breast cancer progression. Patient-tissue associations, cell experiments, and nanoparticle-mediated FAISL silencing in mouse models connect this mechanism to tumor growth and metastasis, while leaving its clinical applicability to be established.

• Lysosomal β-Galactosidase Staining Kit Workflow

  2026-09-23

  Use the Lysosomal β-Galactosidase Staining Kit to visualize acidic lysosomal activity as a brightfield control readout in cell and tissue workflows. Its polystyrene compatibility and precipitation-resistant formulation help separate genuine biology from handling artifacts, especially in senescence and cisplatin-resistance studies.

• Perphenazine: Reliable Cell Assay Workflows

  2026-09-22

  Perphenazine (SKU B6157) supports reproducible viability, mitochondrial-stress, and host-cell defense experiments when concentration, solvent, timing, and storage are controlled. This scenario-based guide translates receptor pharmacology and published phenothiazine evidence into practical decisions for biomedical researchers.

• 25-Hydroxycholesterol Reprograms TAM Immunity

  2026-09-22

  Xiao and colleagues identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint in tumor-associated macrophages. Their study connects lysosomal lipid sensing through GPR155–mTORC1 to AMPKα, STAT6 phosphorylation, ARG1 expression, and improved anti-PD-1 responses after CH25H targeting.

• SB525334: TGF-beta1 Receptor Inhibitor Workflows

  2026-09-21

  SB525334 enables selective interrogation of ALK5-driven TGF-beta signaling in fibrosis, renal disease, cancer, and wound-healing models. This guide translates the compound’s potency and mechanism into practical cell, tissue, and animal workflows while highlighting controls that distinguish pathway-specific effects from general toxicity.

• Cyanine 3 Tyramide for Reliable Cell Assays

  2026-09-21

  Learn how Cyanine 3 Tyramide (SKU K1085) can strengthen orthogonal fluorescence readouts when viability, proliferation, or cytotoxicity assays produce ambiguous results. This scenario-based guide covers TSA compatibility, preparation, interpretation, storage, and practical vendor-selection criteria.

• Perphenazine: D2 Antagonist Research Workflows

  2026-09-20

  Perphenazine combines dopamine D2 receptor antagonism with measurable mitochondrial and host-defense phenotypes, making it useful for both neuropharmacology and translational immunology workflows. This guide connects receptor profiling, mitochondria-mediated cell death induction, macrophage antibacterial assays, and practical troubleshooting while keeping cytotoxicity and pleiotropic signaling under control.

• Clozapine N-oxide (CNO) Assay Workflows

  2026-09-19

  A practical, evidence-based guide to using Clozapine N-oxide (CNO), SKU A3317, in chemogenetic and cell-based workflows. It addresses assay compatibility, stock preparation, control design, data interpretation, and product-selection criteria for more reproducible neuroscience research.

• Clozapine N-oxide (CNO) for Circuit Research

  2026-09-18

  Clozapine N-oxide (CNO) gives researchers reversible, cell-selective control of DREADD-expressing circuits without implanted stimulation hardware. This workflow-oriented guide shows how to use it alongside 40 Hz sensory entrainment assays to distinguish circuit necessity, sufficiency, and downstream effects in epilepsy and broader neuroscience research.

• EZ Cap™ EGFP mRNA: Assay Reliability

  2026-09-18

  Learn how EZ Cap™ EGFP mRNA (SKU R1002) can function as a controlled Cap 1 EGFP mRNA reporter input when delivery, viability, and cytotoxicity results are difficult to interpret. This scenario-based guide connects practical assay controls with published dendritic-cell electroporation findings while clearly separating evidence from workflow recommendations.

• Auditory Activity Sustains Neurogenesis and Cognition

  2026-09-17

  The reference study identifies a causal auditory-to-hippocampal pathway in which cochlear outer hair cell loss weakens PnCvGluT2 input to locus coeruleus norepinephrine neurons, reducing norepinephrine support for adult neurogenesis and cognition. Projection-specific stimulation restores both neurogenic and cognitive outcomes, providing a circuit-level explanation for how hearing loss can affect brain function.

• CDC42 Polarity Controls Intestinal Stem Cell Fate

  2026-09-17

  Zhang and colleagues show that CDC42-dependent epithelial polarity controls the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ–Ereg–EGFR–mTOR cascade, rather than through canonical Wnt signaling. Their genetic and pharmacological experiments distinguish restoration of crypt proliferation and cell-fate balance from restoration of epithelial polarity.

• 7ACC2: A Monocarboxylate Transporter 1 Inhibitor

  2026-09-16

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor for dissecting lactate flux, mitochondrial pyruvate handling, and tumor radiosensitization. This workflow-oriented guide shows how to connect transport assays with metabolic and immunosuppressive tumor-microenvironment readouts without overinterpreting cross-cell effects.

765 records 3/51 page Previous Next 12345 下5页 Last page